Website intended for a NZ health professional readership
Douglas Pharmaceutical’s work in finding new uses for old drugs, plus developing generic drugs, will be boosted by a $35 million research and development facility. Fiona Cassie finds out more about the growing Douglas empire
This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Current clinical guidelines emphasise the significance of having two Adrenaline Auto-Injectors (AAIs) for individuals at risk of anaphylaxis.1*
